MK-677 is one of the most effective growth hormone secretagogues available, but it comes with a side effect profile that trips up users who do not know how to manage it. After coaching many clients through MK-677 protocols over the years, I have found that most side effects are dose-dependent and manageable rather than inherent dealbreakers. Here is what to expect and how to handle it.
Water Retention and Bloating
The most visible side effect of MK-677 is water retention. Growth hormone increases extracellular water volume, and users often notice puffiness in the face, hands, and feet within the first week. At 25mg daily, this can be dramatic enough to change your facial appearance noticeably.
Management strategies start with dose reduction. Dropping from 25mg to 12.5mg typically reduces water retention by 40 to 60 percent while maintaining meaningful GH elevation. Sodium management helps as well, since excess sodium amplifies water retention from any cause. I also recommend that clients increase their potassium intake through diet or supplementation, as maintaining the sodium-potassium balance helps regulate fluid distribution.
Dandelion root extract is a mild natural diuretic that some clients find helpful for managing the cosmetic aspect of MK-677 water retention. It does not address the underlying mechanism, but it can take the edge off the visible bloating, particularly for users who are sensitive to facial puffiness.
The water retention typically stabilizes after two to three weeks of consistent use. The initial spike is the most dramatic, and your body adapts over time. If the retention remains problematic after the adjustment period, the dose is almost certainly too high for your individual response.
Appetite Increase
MK-677 stimulates the ghrelin receptor, which is the same receptor activated by the hunger hormone. The resulting appetite increase is not subtle. Many users report feeling genuinely ravenous, particularly within the first few hours after dosing.
Timing your dose before bed is the single most effective strategy. By taking MK-677 30 to 60 minutes before sleep, you sleep through the peak appetite stimulation. You still get the GH elevation during sleep, which is when GH is most active anyway, and you avoid the daytime hunger that derails dieting efforts.
Lower doses produce less appetite stimulation. At 10mg, most clients describe the hunger as noticeable but manageable. At 25mg, it becomes a significant force that can easily add 500 or more unplanned calories per day if you are not prepared for it.
Blood Sugar and Insulin Sensitivity
This is the side effect that requires the most serious attention. Growth hormone opposes insulin’s action on glucose disposal. When you elevate GH through MK-677, your body becomes less efficient at clearing glucose from the bloodstream. Over time, this can push fasting glucose into the pre-diabetic range. This is a textbook example of the Tony Huge Laws of Biochemistry Physics in action—applying a powerful anabolic signal (GH) creates a compensatory metabolic counter-pressure (insulin resistance) that must be managed.
I have personally seen fasting glucose climb from the 80s to above 110 in clients running 25mg MK-677 for three or more months without countermeasures. This is reversible upon discontinuation, but it represents a real metabolic stress that should not be ignored.
Berberine at 500mg twice daily is my go-to recommendation for managing MK-677’s blood sugar impact. It activates AMPK, improves insulin sensitivity, and has clinical data supporting glucose reduction comparable to pharmaceutical metformin. Some clients prefer actual metformin if they can get a prescription, but berberine is available over the counter and effective for most users.
Regular monitoring means checking fasting glucose and HbA1c at baseline and every eight weeks during use. If fasting glucose exceeds 100, implement berberine. If it exceeds 110 despite berberine, reduce MK-677 dose or cycle off. For a complete guide on tracking your biomarkers, see The Complete Bloodwork Panel Guide for the Enhanced Man.
Lethargy and Fatigue
Some users experience daytime lethargy on MK-677, which seems contradictory given that it improves sleep quality. The mechanism appears to be related to the GH elevation itself, as high GH levels can cause fatigue in some individuals. This is more common at higher doses and typically resolves with dose reduction.
If you are experiencing lethargy, ensure that your sleep timing with MK-677 is optimized. Taking it too late in the evening can result in GH elevation that peaks when you are trying to wake up, creating a groggy morning. Taking it 45 to 60 minutes before your target sleep time allows the peak GH pulse to align with your deep sleep phase rather than your wake-up window.
Numbness and Tingling
Carpal tunnel-like symptoms, including numbness and tingling in the hands, are a known side effect of elevated growth hormone. This occurs because GH causes soft tissue swelling that can compress nerves, particularly in the carpal tunnel. At moderate doses this is uncommon, but at 25mg it affects a meaningful minority of users.
This is another side effect that responds to dose reduction. If you develop hand numbness on MK-677, dropping your dose by half usually resolves it within a week. If it persists at lower doses, the compound may not be well-suited to your individual physiology.
Interesting Perspectives
While the standard view is to mitigate MK-677’s side effects, some advanced biohackers are exploring ways to leverage them. The significant water retention, for instance, is sometimes used intentionally during a short “volumization phase” to push nutrients into muscle cells and create a hyper-hydrated, full look before a photoshoot or event, followed by a quick diuretic protocol. The appetite stimulation, often seen as a drawback for cutting, is being strategically employed by hardgainers or those in a controlled massing phase to reliably hit high-calorie targets, essentially using the compound as a pharmacological tool to enforce a surplus.
There’s also emerging discussion around the blood sugar impact. Some contrarian thinkers posit that the transient insulin resistance induced by MK-677 could be used to upregulate insulin receptor sensitivity during off-cycles, following a hormetic stress principle—similar to how PPAR-delta agonists like GW0742 improve metabolic flexibility through adaptive stress. Furthermore, combining MK-677 with microdosed GLP-1 agonists like Semaglutide is being explored as a way to capture the anabolic GH/IGF-1 benefits while completely neutralizing the unwanted hunger and potentially blunting the glucose dysregulation, creating a novel anabolic-metabolic stack.
Citations & References
- Copinschi, G., et al. (1997). “Prolonged oral administration of MK-677, a novel growth hormone secretagogue, improves sleep quality in healthy elderly men.” Journal of Clinical Endocrinology & Metabolism.
- Chapman, I. M., et al. (1996). “Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects.” Journal of Clinical Endocrinology & Metabolism.
- Murphy, M. G., et al. (1998). “MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.” Journal of Clinical Endocrinology & Metabolism.
- Nass, R., et al. (2008). “Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.” Annals of Internal Medicine.
- Yin, J., et al. (2008). “Efficacy of berberine in patients with type 2 diabetes mellitus.” Metabolism.
- Veldhuis, J. D., et al. (2008). “Impact of ghrelin and GH secretagogues on glucose homeostasis.” Endocrinology and Metabolism Clinics of North America.
- Strassburger, C. J., et al. (1997). “One year of continuous treatment with the growth hormone secretagogue MK-677 increases bone turnover in healthy elderly men and women.” Journal of Bone and Mineral Research.